|
1
|
Fitzmaurice C, Allen C, Barber RM,
Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O,
Dandona R, Dandona L, et al Global Burden of Disease Cancer
Collaboration: Global, regional, and national cancer incidence,
mortality, years of life lost, years lived with disability, and
disability-adjusted life-years for 32 cancer groups, 1990 to 2015:
A systematic analysis for the global burden of disease study. JAMA
Oncol. 3:524–548. 2017. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: Unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar
|
|
4
|
Sevin BU, Nadji M, Averette HE, Hilsenbeck
S, Smith D and Lampe B: Microinvasive carcinoma of the cervix.
Cancer. 70:2121–2128. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Massad LS, Einstein MH, Huh WK, Katki HA,
Kinney WK, Schiffman M, Solomon D, Wentzensen N and Lawson HW; 2012
ASCCP Consensus Guidelines Conference: 2012 updated consensus
guidelines for the management of abnormal cervical cancer screening
tests and cancer precursors. Obstet Gynecol. 121:829–846. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bevis KS and Biggio JR: Cervical
conization and the risk of preterm delivery. Am J Obstet Gynecol.
205:19–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boshart M, Gissmann L, Ikenberg H,
Kleinheinz A, Scheurlen W and zur Hausen H: A new type of
papillomavirus DNA, its presence in genital cancer biopsies and in
cell lines derived from cervical cancer. EMBO J. 3:1151–1157.
1984.PubMed/NCBI
|
|
8
|
Dürst M, Gissmann L, Ikenberg H and zur
Hausen H: A papillomavirus DNA from a cervical carcinoma and its
prevalence in cancer biopsy samples from different geographic
regions. Proc Natl Acad Sci USA. 80:3812–3815. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ;
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dyson N, Howley PM, Münger K and Harlow E:
The human papilloma virus-16 E7 oncoprotein is able to bind to the
retinoblastoma gene product. Science. 243:934–937. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: Pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Werness BA, Levine AJ and Howley PM:
Association of human papillomavirus types 16 and 18 E6 proteins
with p53. Science. 248:76–79. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Da Silva DM, Eiben GL, Fausch SC,
Wakabayashi MT, Rudolf MP, Velders MP and Kast WM: Cervical cancer
vaccines: Emerging concepts and developments. J Cell Physiol.
186:169–182. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: potent and specific genetic interference by
double- stranded RNA in Caenorhabditis elegans. Nature.
391:806–811. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caplen NJ, Parrish S, Imani F, Fire A and
Morgan RA: Specific inhibition of gene expression by small
double-stranded RNAs in invertebrate and vertebrate systems. Proc
Natl Acad Sci USA. 98:9742–9747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Elbashir SM, Harborth J, Lendeckel W,
Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs
mediate RNA interference in cultured mammalian cells. Nature.
411:494–498. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scherr M and Eder M: Gene silencing by
small regulatory RNAs in mammalian cells. Cell Cycle. 6:444–449.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paddison PJ and Hannon GJ: RNA
interference: The new somatic cell genetics? Cancer Cell. 2:17–23.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mueller C and Flotte TR: Clinical gene
therapy using recombinant adeno-associated virus vectors. Gene
Ther. 15:858–863. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Z, Asokan A and Samulski RJ:
Adeno-associated virus serotypes: Vector toolkit for human gene
therapy. Mol Ther. 14:316–327. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grieger JC and Samulski RJ:
Adeno-associated virus vectorology, manufacturing, and clinical
applications. Methods Enzymol. 507:229–254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao G, Vandenberghe LH, Alvira MR, Lu Y,
Calcedo R, Zhou X and Wilson JM: Clades of Adeno-associated viruses
are widely disseminated in human tissues. J Virol. 78:6381–6388.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao GP, Alvira MR, Wang L, Calcedo R,
Johnston J and Wilson JM: Novel adeno-associated viruses from
rhesus monkeys as vectors for human gene therapy. Proc Natl Acad
Sci USA. 99:11854–11859. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rutledge EA, Halbert CL and Russell DW:
Infectious clones and vectors derived from adeno-associated virus
(AAV) serotypes other than AAV type 2. J Virol. 72:309–319.
1998.PubMed/NCBI
|
|
25
|
Takeda S, Takahashi M, Mizukami H,
Kobayashi E, Takeuchi K, Hakamata Y, Kaneko T, Yamamoto H, Ito C,
Ozawa K, et al: Successful gene transfer using adeno-associated
virus vectors into the kidney: Comparison among adeno-associated
virus serotype 1–5 vectors in vitro and in vivo. Exp Nephrol.
96:e119–e126. 2004. View Article : Google Scholar
|
|
26
|
Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou
J, Xu G, Meng L, Lu Y, Wang S, et al: RNA interference against
HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical
cancer cells and apoptosis via upregulation of Rb and p53.
Apoptosis. 13:273–281. 2008. View Article : Google Scholar
|
|
27
|
Hata K, Mizukami H, Sadakane O, Watakabe
A, Ohtsuka M, Takaji M, Kinoshita M, Isa T, Ozawa K and Yamamori T:
DNA methylation and methyl-binding proteins control differential
gene expression in distinct cortical areas of macaque monkey. J
Neurosci. 33:19704–19714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsushita T, Elliger S, Elliger C,
Podsakoff G, Villarreal L, Kurtzman GJ, Iwaki Y and Colosi P:
Adeno-associated virus vectors can be efficiently produced without
helper virus. Gene Ther. 5:938–945. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yagi H, Ogura T, Mizukami H, Urabe M,
Hamada H, Yoshikawa H, Ozawa K and Kume A: Complete restoration of
phenylalanine oxidation in phenylketonuria mouse by a
self-complementary adeno-associated virus vector. J Gene Med.
13:114–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Adhim Z, Otsuki N, Kitamoto J, Morishita
N, Kawabata M, Shirakawa T and Nibu K: Gene silencing with siRNA
targeting E6/E7 as a therapeutic intervention against head and neck
cancer-containing HPV16 cell lines. Acta Otolaryngol. 133:761–771.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fehrmann F and Laimins LA: Human
papillomaviruses: Targeting differentiating epithelial cells for
malignant transformation. Oncogene. 22:5201–5207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: A meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sherman L and Alloul N: Human
papillomavirus type 16 expresses a variety of alternatively spliced
mRNAs putatively encoding the E2 protein. Virology. 191:953–959.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smotkin D, Prokoph H and Wettstein FO:
Oncogenic and nononcogenic human genital papillomaviruses generate
the E7 mRNA by different mechanisms. J Virol. 63:1441–1447.
1989.PubMed/NCBI
|
|
35
|
Yoshinouchi M, Yamada T, Kizaki M, Fen J,
Koseki T, Ikeda Y, Nishihara T and Yamato K: In vitro and in vivo
growth suppression of human papillomavirus 16-positive cervical
cancer cells by E6 siRNA. Mol Ther. 8:762–768. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View Article : Google Scholar
|
|
37
|
Fujii T, Saito M, Iwasaki E, Ochiya T,
Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, et al:
Intratumor injection of small interfering RNA-targeting human
papillomavirus 18 E6 and E7 successfully inhibits the growth of
cervical cancer. Int J Oncol. 29:541–548. 2006.PubMed/NCBI
|
|
38
|
Yamato K, Yamada T, Kizaki M, Ui-Tei K,
Natori Y, Fujino M, Nishihara T, Ikeda Y, Nasu Y, Saigo K, et al:
New highly potent and specific E6 and E7 siRNAs for treatment of HP
V16 positive cervical cancer. Cancer Gene Ther. 15:140–153. 2008.
View Article : Google Scholar
|
|
39
|
Jonson AL, Rogers LM, Ramakrishnan S and
Downs LS Jr: Gene silencing with siRNA targeting E6/E7 as a
therapeutic intervention in a mouse model of cervical cancer.
Gynecol Oncol. 111:356–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu S, Meng L, Wang S, Wang W, Xi L, Tian
X, Chen G, Wu Y, Zhou J, Xu G, et al: Reversal of the malignant
phenotype of cervical cancer CaSki cells through adeno-associated
virus-mediated delivery of HPV16 E7 antisense RNA. Clin Cancer Res.
12:2032–2037. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kennedy EM, Kornepati AV, Goldstein M,
Bogerd HP, Poling BC, Whisnant AW, Kastan MB and Cullen BR:
Inactivation of the human papillomavirus E6 or E7 gene in cervical
carcinoma cells by using a bacterial CRIspR/Cas RNA-guided
endonuclease. J Virol. 88:11965–11972. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhen S, Hua L, Takahashi Y, Narita S, Liu
YH and Li Y: In vitro and in vivo growth suppression of human
papillomavirus 16-positive cervical cancer cells by CRIspR/Cas9.
Biochem Biophys Res Commun. 450:1422–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hu Z, Ding W, Zhu D, Yu L, Jiang X, Wang
X, Zhang C, Wang L, Ji T, Liu D, et al: TALEN-mediated targeting of
HPV oncogenes ameliorates HPV-related cervical malignancy. J Clin
Invest. 125:425–436. 2015. View Article : Google Scholar :
|
|
44
|
Ran FA, Cong L, Yan WX, Scott DA,
Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS, et
al: In vivo genome editing using Staphylococcus aureus Cas9.
Nature. 520:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ahn WS, Bae SM, Lee HJ, Kim YW, Lee JM,
Namkoong SE, Kim CK, Kim YW and Jin HS: Development of anticancer
gene vaccine interact with human papillomavirus oncoprotein
inhibition. Int J Gynecol Cancer. 16:270–276. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Paavonen J, Jenkins D, Bosch FX, Naud P,
Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC,
Castellsague X, et al HPV pATRICIA study group: Efficacy of a
prophylactic adjuvanted bivalent L1 virus-like-particle vaccine
against infection with human papillomavirus types 16 and 18 in
young women: An interim analysis of a phase III double-blind,
randomised controlled trial. Lancet. 369:2161–2170. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Romanowski B: Long term protection against
cervical infection with the human papillomavirus: Review of
currently available vaccines. Hum Vaccin. 7:161–169. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sardi JE, Giaroli A, Sananes C, Ferreira
M, Soderini A, Bermudez A, Snaidas L, Vighi S, Gomez Rueda N and di
Paola G: long-term follow-up of the first randomized trial using
neoadjuvant chemotherapy in stage Ib squamous carcinoma of the
cervix: The final results. Gynecol Oncol. 67:61–69. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Benedetti-Panici P, Greggi S, Colombo A,
Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F,
Zola P, Mangioni C, et al: Neoadjuvant chemotherapy and radical
surgery versus exclusive radiotherapy in locally advanced squamous
cell cervical cancer: Results from the Italian multicenter
randomized study. J Clin Oncol. 20:179–188. 2002. View Article : Google Scholar : PubMed/NCBI
|
